Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05423509 · ClinicalTrials.gov registry record · NA
Myofascial and Articular Treatment of Adolescent Idiopathic Scoliosis
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT05423509: Completed NA study, sponsored by University of New Mexico.
NCT05423509 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05423509, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Randomized controlled trial of participants with scoliosis into standard treatment with observation/bracing and the other group will have the added treatment of dynamic myofascial manipulation for 6 months.
Primary Outcome
Cobb angle as measured on x-ray
Interventions
- OTHER Dynamic myofascial manipulation
- OTHER Standard AIS treatment with observation or bracing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2022-06-10 |
| Phase | NA |
What the finished NCT05423509 record still lists
NCT05423509 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Dynamic myofascial manipulation is the first listed.
NCT05423509 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05423509 about?
NCT05423509 is a clinical study titled "Myofascial and Articular Treatment of Adolescent Idiopathic Scoliosis". Randomized controlled trial of participants with scoliosis into standard treatment with observation/bracing and the other group will have the added treatment of dynamic myofascial manipulation for 6 months.
What is the current status of trial NCT05423509?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2020-12-01. Estimated completion is 2022-06-10.
What interventions are being tested in trial NCT05423509?
The interventions under investigation include: Dynamic myofascial manipulation (OTHER), Standard AIS treatment with observation or bracing (OTHER).
Who is sponsoring clinical trial NCT05423509?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05423509's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI